Form D · Private Equity Fund
Carlyle-Healthscope Partners (Scot), L.P.
Washington, DC · CIK 0001503649
Offering snapshot reported Oct 19, 2010 · SEC filing
- Reported sold
- $142M Indefinite offering
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 11, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 19, 2010 | Initial | $142,233,995 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Pooled investment fund, Other
- Exemptions
- 06, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149279
Limited Partnership Interests
Source: Form D, filed Oct 19, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Curtis Buser | Director |
| N/A Cap Iii General Partners (Scot), L.P. | Promoter |
| N/A Cap Iii Ltd. | Promoter |
| William Conway | Director |
| Daniel D'aniello | Director |
| David Rubenstein | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1001 Pennsylvania Avenue, Nw
Washington, DC, 20004-2505
Washington, DC, 20004-2505